Cargando…

The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors

Detalles Bibliográficos
Autores principales: Darsalia, Vladimer, Larsson, Martin, Klein, Thomas, Patrone, Cesare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822625/
https://www.ncbi.nlm.nih.gov/pubmed/29466979
http://dx.doi.org/10.1186/s12933-018-0674-3
_version_ 1783301727663947776
author Darsalia, Vladimer
Larsson, Martin
Klein, Thomas
Patrone, Cesare
author_facet Darsalia, Vladimer
Larsson, Martin
Klein, Thomas
Patrone, Cesare
author_sort Darsalia, Vladimer
collection PubMed
description
format Online
Article
Text
id pubmed-5822625
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58226252018-02-26 The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors Darsalia, Vladimer Larsson, Martin Klein, Thomas Patrone, Cesare Cardiovasc Diabetol Commentary BioMed Central 2018-02-21 /pmc/articles/PMC5822625/ /pubmed/29466979 http://dx.doi.org/10.1186/s12933-018-0674-3 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Darsalia, Vladimer
Larsson, Martin
Klein, Thomas
Patrone, Cesare
The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors
title The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors
title_full The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors
title_fullStr The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors
title_full_unstemmed The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors
title_short The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors
title_sort high need for trials assessing functional outcome after stroke rather than stroke prevention with glp-1 agonists and dpp-4 inhibitors
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822625/
https://www.ncbi.nlm.nih.gov/pubmed/29466979
http://dx.doi.org/10.1186/s12933-018-0674-3
work_keys_str_mv AT darsaliavladimer thehighneedfortrialsassessingfunctionaloutcomeafterstrokeratherthanstrokepreventionwithglp1agonistsanddpp4inhibitors
AT larssonmartin thehighneedfortrialsassessingfunctionaloutcomeafterstrokeratherthanstrokepreventionwithglp1agonistsanddpp4inhibitors
AT kleinthomas thehighneedfortrialsassessingfunctionaloutcomeafterstrokeratherthanstrokepreventionwithglp1agonistsanddpp4inhibitors
AT patronecesare thehighneedfortrialsassessingfunctionaloutcomeafterstrokeratherthanstrokepreventionwithglp1agonistsanddpp4inhibitors
AT darsaliavladimer highneedfortrialsassessingfunctionaloutcomeafterstrokeratherthanstrokepreventionwithglp1agonistsanddpp4inhibitors
AT larssonmartin highneedfortrialsassessingfunctionaloutcomeafterstrokeratherthanstrokepreventionwithglp1agonistsanddpp4inhibitors
AT kleinthomas highneedfortrialsassessingfunctionaloutcomeafterstrokeratherthanstrokepreventionwithglp1agonistsanddpp4inhibitors
AT patronecesare highneedfortrialsassessingfunctionaloutcomeafterstrokeratherthanstrokepreventionwithglp1agonistsanddpp4inhibitors